Antibiotic Therapy
11
0
0
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
9%
1 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (11)
Acceptability and Adherence to Different Dosing Regimens of the Multistrain Probiotic Vivomixx Neo® 460 in Adults Receiving Antibiotic Therapy.
Multicenter Phase II Trial of NRICM102 Combined With Standard Therapy in Pneumonia
Oritavancin for CIED Infections With MDR Gram-positive Cocci
Comparison of G-CSF & Antibiotics Versus Antibiotics Alone in Resolution of Febrile Neutropenia
Delayed Antibiotic Therapy in Non-severe Ventilator Acquired Pneumonia (VAP)
Therapeutic Monitoring of Antibiotics in Intensive Care Patients: a Cohort Study PopTDM-ICU
Evaluating a Novel Individualised Treatment Strategy for Carbapenem-Resistant Gram-Negative Bacteria Infections
Rapid PCR to Guide Antibiotic Therapy at the Time of Prostate Biopsy
Appendectomy Versus Conservative Treatment for Uncomplicated Acute Appendicitis
Procalcitonin-Guided Antibiotic Therapy in Bronchiectasis
Probiotic Product in Healthy Adults Undergoing Antibiotic Treatment